• By:admin

Claim Filed against Zantac Maker over the Drug’s Link to Cancer

Legal action is underway regarding the potential link between Zantac heartburn medication and cancer. The US Food and Drug Administration (FDA) is investigating Zantac (ranitidine) after it was determined that the popular heartburn and acid reflux medication contains potentially high levels of N-nitrosodimethylamine (NDMA). NDMA is a known carcinogen.

As a result of the finding, sales of the drug have been suspended in US stores. Three pharmaceutical companies have issued recalls for their versions of ranitidine.

People are exposed to naturally NDMA in foods, drinks, and the environment, but the dosage is small enough that is not believed to be dangerous. But the amount contained in Zantac is dangerous – anywhere from 3,000 to 26,000 times higher than what the FDA considers safe.

There is also concern about the risk increasing over time based on how the medication is stored.

According to the FDA, “… the impurity in some ranitidine products increases over time and when stored at higher than room temperatures and may result in consumer exposure to unacceptable levels of this impurity.”

The FDA is still trying to determine how NDMA was introduced into Zantac and other medications like it. It is known to be unintentionally produced in and released from industrial sources via chemical reactions, including those that involve alkylamines. NDMA is also known to contaminate air, soil, and water.

Why is NDMA Dangerous?

The Environmental Protection Agency (EPA) describes NDMA as a “semi-volatile organic chemical.” It is formed through industrial and natural processes but is only produced commercially and in its pure form for research purposes in the United States. It was previously used in the production of antioxidants, additives for lubricants, rocket fuel, and softeners for copolymers. It is also an unintended byproduct of the chlorination of wastewater and drinking water at treatment plants that disinfect with chloramines.

The primary reason exposure to high levels of NDMA is dangerous is because it’s a known carcinogen.

It has been linked to several different types of cancer, including:

  • Stomach
  • Small intestine
  • Bowel
  • Colon
  • Liver
  • Prostate
  • Leukemia
  • Non-Hodgkin’s Lymphoma

The degree of risk varies among the types of cancer and from person-to-person.

In addition to cancer, overexposure to NDMA carries a variety of other risks and triggers several side effects, including:

  • Abdominal cramps
  • Dizziness
  • Fever
  • Headaches
  • Jaundice
  • Nausea
  • Reduced liver, kidney, and lung function
  • Vomiting

Makers of Zantac Might Have Been Aware of the Risks

Many of those affected after using Zantac and other versions ranitidine have filed claims against the manufacturers of the drugs. According to the claims, manufacturers knew of the high levels of NDMA in their products and hid the danger from consumers.

Lawsuits claim manufacturers of Zantac were negligent and guilty of wrongdoing concerning the design, development, manufacture, testing, packaging, promoting, marketing, advertising, distribution, labeling, and/or sale of the drug Zantac.

Additionally, claims allege negligence, several breaches of contract and warranty, negligent misrepresentation, fraud, and deceit, as well as a violation of the New York Consumer Protection Act. One lawsuit also alleges loss of consortium.

Claims call the product “defective, dangerous to human health, unfit, and unsuitable to be marketed and sold in commerce…” Lawyers for plaintiffs believe that research will show that this will be “… one of the gravest public health frauds in modern times.” Plaintiffs have also called Zantac a “cancerous poison.”

Those who used the medication and can prove they did so and were later diagnosed with any of the types of cancer linked to NDMA exposure, and can prove that to be the case through medical records could potentially pursue legal action. Proving a link between the use of a product and the development of a serious side effect such as cancer can be complex. Anyone who believes they have been affected should speak to an attorney familiar with the situation.

Related Post

VIEW all
Teva, Major Pharmacies Found Liable for Actions in Opioid Crisis in New York, Ohio
  • By:B. Shaffer

Pharmaceutical manufacturing giant, Teva has been found guilty of its role in the opioid crisis in the state of New York. In a separate ruling in Ohio, major pharmacies Walgreens, CVS and Walmart have been found liable for helping to create an oversupply of drugs leading to the opioid epidemic. The findings are in addition to others reached in federal and other state courts. Teva Found Guilty in State of New York Opioid Crisis A New York jury has ruled …

Opioid Epidemic
Judge Rejects Opioid Lawsuit Settlement for Purdue Pharma’s Sackler Family
  • By:B. Shaffer

A federal judge has rejected Purdue Pharma’s Opioid Lawsuit Settlement agreement releasing the Sackler Family from liability over OxyContin. The agreement had been reached on December 16, 2021, in bankruptcy court and would settle thousands of Opioid lawsuits filed by government agencies and people who had been harmed by OxyContin. Through the bankruptcy court agreement, the Sackler family was to be allowed to pay $4.5 billion to avoid civil liability over their involvement in the Purdue Pharma-OxyContin Opioid lawsuit battles. …

weight loss drug
Weight Loss Drug Removed from Market after Cancer Linked Identified
  • By:B. Shaffer

Eisai, Inc. voluntarily pulled its weight-loss drug Belviq from the market in February 2020 after it was determined that the drug poses a slightly increased risk of cancer. Despite the recall of the product, Eisai said it did not believe the FDA’s interpretation of the latest round of data on the drug’s safety and stated that it still believes the benefits outweigh the risks. According to the FDA, patients currently using Belviq should stop doing so immediately. They should dispose …

Have you been affected by a drug or device listed?